Methylxanthine Therapy for Apnea of Prematurity: Evaluation of Treatment Benefits and Risks at Age 5 Years in the International Caffeine for Apnea of Prematurity (CAP) Trial-Reference-Cited by-同舟云学术

Methylxanthine Therapy for Apnea of Prematurity: Evaluation of Treatment Benefits and Risks at Age 5 Years in the International Caffeine for Apnea of Prematurity (CAP) Trial

Published:2005 Issue:3 Volume:88 Page:208-213
ISSN:1661-7800
Container-title:Neonatology
language:en
Short-container-title:Neonatology

Author:

Schmidt Barbara

Publisher

S. Karger AG

Subject

Developmental Biology,Pediatrics, Perinatology and Child Health

Reference57 articles.

1. Preterm outcomes research: A critical component of neonatal intensive care

2. Outcome at 5 Years of Age of Children 23 to 27 Weeks' Gestation: Refining the Prognosis

3. Neurologic and Developmental Disability at Six Years of Age after Extremely Preterm Birth

4. Cognitive and Behavioral Outcomes of School-Aged Children Who Were Born Preterm

5. Extremely premature (=< 800 g) schoolchildren: multiple areas of hidden disability

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Hypoxic-Ischemic Encephalopathy Using Measures Other Than Therapeutic Hypothermia;Principles of Neonatology;2024

2. Comparing the efficacy in reducing brain injury of different neuroprotective agents following neonatal hypoxia–ischemia in newborn rats: a multi-drug randomized controlled screening trial;Scientific Reports;2023-06-10

3. FDA approved five-membered ring fused pyrimidine-based derivatives and their biological properties;Fused Pyrimidine-Based Drug Discovery;2023

4. Comparative efficacy and safety of caffeine citrate and aminophylline in treating apnea of prematurity: A systematic review and meta-analysis;PLOS ONE;2022-09-19

5. The Conflicting Role of Caffeine Supplementation on Hyperoxia-Induced Injury on the Cerebellar Granular Cell Neurogenesis of Newborn Rats;Oxidative Medicine and Cellular Longevity;2022-05-31